Gainers
- Pyxis Oncology (NASDAQ:PYXS) stock moved upwards by 14.0% to $3.02 during Thursday's after-market session. Pyxis Oncology's trading volume hit 1.7 million shares by close, accounting for 2253.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $99.1 million.
- INVO Bioscience (NASDAQ:INVO) shares moved upwards by 11.11% to $1.8. The market value of their outstanding shares is at $21.7 million.
- HeartBeam (NASDAQ:BEAT) stock increased by 10.17% to $1.84. The company's market cap stands at $63.1 million.
- ASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 9.16% to $0.75. The market value of their outstanding shares is at $51.9 million.
- Celsion (NASDAQ:CLSN) shares moved upwards by 7.4% to $3.48. The company's market cap stands at $24.7 million.
- BioSig Technologies (NASDAQ:BSGM) stock increased by 7.35% to $1.01. The market value of their outstanding shares is at $38.8 million.
Losers
- SCYNEXIS (NASDAQ:SCYX) shares decreased by 20.7% to $2.49 during Thursday's after-market session. Trading volume for this security closed at 218.5K, accounting for 90.2% of its average full-day volume over the last 100 days. The company's market cap stands at $72.0 million.
- 4d pharma (NASDAQ:LBPS) shares decreased by 13.98% to $4.0. The market value of their outstanding shares is at $90.1 million.
- Globus Medical (NYSE:GMED) shares declined by 11.4% to $70.0. Today's trading volume for this security ended up closing at 81.7K shares, which is 13.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $7.1 billion.
- Qilian Intl Hldg Gr (NASDAQ:QLI) stock decreased by 9.1% to $1.7. The market value of their outstanding shares is at $60.7 million.
- Plus Therapeutics (NASDAQ:PSTV) stock decreased by 6.11% to $0.83. The company's market cap stands at $18.4 million. As per the press release, Q1 earnings came out today.
- Cytek Biosciences (NASDAQ:CTKB) stock decreased by 5.2% to $9.3. The market value of their outstanding shares is at $1.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
